Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Acquired by Barclays PLC

Barclays PLC increased its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 144.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 193,446 shares of the company's stock after buying an additional 114,191 shares during the quarter. Barclays PLC owned about 0.10% of Alignment Healthcare worth $2,287,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ALHC. nVerses Capital LLC purchased a new position in Alignment Healthcare during the 3rd quarter valued at $95,000. Principal Financial Group Inc. boosted its stake in shares of Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company's stock valued at $106,000 after purchasing an additional 2,077 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare in the third quarter worth about $131,000. Creative Planning increased its stake in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company's stock worth $147,000 after buying an additional 2,072 shares during the period. Finally, Mackenzie Financial Corp lifted its holdings in Alignment Healthcare by 110.0% during the 2nd quarter. Mackenzie Financial Corp now owns 36,526 shares of the company's stock valued at $286,000 after buying an additional 19,129 shares in the last quarter. Institutional investors own 86.19% of the company's stock.

Insider Activity at Alignment Healthcare

In other news, CEO John E. Kao sold 90,000 shares of the company's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $11.33, for a total transaction of $1,019,700.00. Following the sale, the chief executive officer now owns 2,543,100 shares of the company's stock, valued at approximately $28,813,323. This represents a 3.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $10.77, for a total value of $323,100.00. Following the completion of the sale, the insider now owns 1,726,097 shares in the company, valued at approximately $18,590,064.69. The trade was a 1.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 653,546 shares of company stock worth $7,875,008. 6.60% of the stock is currently owned by company insiders.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock traded up $0.12 on Thursday, hitting $10.84. 670,560 shares of the company were exchanged, compared to its average volume of 1,185,411. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a 50-day moving average price of $11.87 and a 200 day moving average price of $10.26. The stock has a market capitalization of $2.08 billion, a price-to-earnings ratio of -14.08 and a beta of 1.42. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.25.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.14). The business had revenue of $692.43 million during the quarter, compared to the consensus estimate of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business's revenue was up 51.6% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.19) EPS. As a group, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Stephens upgraded Alignment Healthcare from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $13.00 to $17.00 in a research note on Tuesday, December 3rd. KeyCorp assumed coverage on shares of Alignment Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a research report on Wednesday, October 30th. Finally, UBS Group lifted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $11.44.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.